secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2024-08-14T23:59:59+00:00
Accession:  0001140361-24-037184
Event type: debt
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA repays $30M of revolver; total debt reduced to $105M, a 22% reduction
--------------------------------------------------------------------------

- Repaid $30M from $72.5M Ares Capital revolver with no prepayment penalties.
- Total gross debt reduced to $105M ($62.5M term loan + $42.5M revolver).
- Paydown funded from cash on hand generated organically.
- Lower interest expense expected to enhance earnings growth.
- Company expects further reduction and optimization of capital costs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124037184/0001140361-24-037184-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124037184/ef20034127_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-037184

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer